The Cancer Immunotherapy Market Will Increase to Nearly $9 Billion Across the World’s Major Pharmaceutical Markets In 2022

Immune Checkpoint Inhibitors Will Hold an Impressive 85 Percent Market Share, According to Findings from Decision Resources Group July 9, 2014 Decision Resources Group finds that the immunotherapy market will experience considerable growth through 2022, increasing from $1.1 billion in 2012 to nearly $9 billion in 2022 (corresponding to 23.8 percent annual growth) in the United States, France, Germany, Italy, …